Latest company news on US-listed stocks: earnings, guidance, deals, management changes and product announcements, linked to each ticker page.
Nasdaq
Linde (NASDAQ: LIN) has been selling gases—nitrogen, oxygen, argon, and hydrogen—for more than a century, mostly to hospitals, food companies, and refineries. Now, though, it’s…
Nasdaq
SpaceX stock surges to its highest level since June as Morgan Stanley turns bullish. Here are some ETFs to consider for SpaceX exposure.
Nasdaq
(RTTNews) - Pfizer Inc. (PFE) announced that its Board of Directors has declared a fourth-quarter 2026 cash dividend of $0.43 per share on the company's common stock.
Nasdaq
Interactive Brokers' September metrics show strong client, equity and margin growth, with its automated platform supporting scalable expansion.
Nasdaq
PYPL vs. V: Which Stock Is the Better Value Option?
Nasdaq
PFE vs. JNJ: Which Stock Is the Better Value Option?
Nasdaq
TGS vs. MPLX: Which Stock Is the Better Value Option?
Nasdaq
AMG vs. BLK: Which Stock Is the Better Value Option?
Nasdaq
LMT vs. HWM: Which Stock Is the Better Value Option?
Nasdaq
PRGS vs. SNPS: Which Stock Is the Better Value Option?
Nasdaq
TPC wins a $315M Coast Guard contract in Alaska, expanding its federal infrastructure portfolio and supporting long-term revenue visibility.
Nasdaq
Applied Materials' AI-driven WFE exposure, record AGS growth and capacity expansion support its outlook.
Nasdaq
J&J's MedTech faces Abiomed and competitive pressures, but Vision, Orthopedics and Surgery could drive a stronger second half.
Nasdaq
Merck's 7% dip may offer a buying opportunity as Keytruda drives growth and new products and pipeline assets strengthen its post-2028 outlook.
Nasdaq
Morgan Stanley's integrated model spans banking, wealth and asset management, supporting growth as deal activity recovers and client assets expand.
Nasdaq
CNC is narrowing its 2027 Medicare Advantage footprint as elevated costs pressure plan economics, with a sharper focus on dual eligibles.
Nasdaq
LMT's $209M Navy electronic warfare award, with options up to $1.71B, boosts visibility as fleet modernization drives demand.
Nasdaq
Investors need to pay close attention to BNY stock based on the movements in the options market lately.
Nasdaq
BP simplifies its portfolio, selling non-core assets and prioritizes higher-return projects to boost margins, cash flow and shareholder value.
Nasdaq
NBIS stock surges 110% in six months as AI demand, expanding capacity and improving profitability fuel growth, but valuation raises questions.
Nasdaq
D's 53.8-GW contracted data center capacity and $65B investment plan support rate-base expansion and long-term earnings growth.
Nasdaq
ABBV's epcoritamab plus R-CHOP cut progression or death risk by 51% in frontline DLBCL, meeting the phase III study's PFS goal.
Nasdaq
NOC's $66 million MQ-4C Triton order underscores rising demand for unmanned surveillance, upgrades and long-term fleet sustainment.
Nasdaq
ASML's EUV technology is central to advanced chip production, while AI-driven tools and Samsung collaboration support its semiconductor ambitions.
Nasdaq
GOOGL's Waymo leads robotaxi deployments, but TSLA is betting its camera-only Cybercab and manufacturing scale can drive lower-cost expansion.
Nasdaq
Microsoft's 41% six-month gain reflects strong Azure and AI demand, but heavy capex and valuation pressure raise questions for new investors.
Nasdaq
GNRC's 57.8% YTD surge reflects booming data center demand and a major Amazon deal, but residential softness and margin risks loom.
Nasdaq
SANM's integrated manufacturing capabilities position it to benefit from rising demand for industrial automation, electrification and renewable energy solutions.
Nasdaq
NFLX's rising live sports costs are testing margin expansion as rights spending outpaces amortization and sports deliver limited viewing hours.
Headlines and summaries belong to their publishers; links open the original article on the publisher's site. MetaCap does not republish third-party articles.
Market data is delayed at least 15 minutes and provided for informational purposes only. Not investment advice. Full disclaimer